Literature DB >> 15300900

Possible causes of central pontine myelinolysis after liver transplantation.

Jun Yu1, Shu-Sen Zheng, Ting-Bo Liang, Yan Shen, Wei-Lin Wang, Qing-Hong Ke.   

Abstract

AIM: To sum up the clinical characteristics of patients with central pontine myelinolysis (CPM) after orthotopic liver transplantation (OLT) and to document the possible causes of CPM.
METHODS: Data of 142 patients undergoing OLT between January 1999 to May 2003 were analyzed retrospectively. Following risk factors during perioperation were analyzed in patients with and without CPM: primary liver disease, preoperative serum sodium level, magnesium level and plasma osmolality, fluctuation degree of serum sodium concentration, and immunosuppressive drug level, etc.
RESULTS: A total of 13 (9.2%) neurologic symptoms appeared in 142 patients post-operation including 5 cases (3.5%) with CPM and 8 cases (5.6%) with cerebral hemorrhage or infarct. Two patients developing CPM after OLT had a hyponatremia history before operation (serum sodium<130 mmol/L), their mean serum sodium level was 130.6 +/- 5.54 mmol/L. The serum sodium level was significantly lower in CPM patients than in patients without neurologic complications or with cerebral hemorrhage/infarct (P<0.05). The increase in serum sodiumduring perioperative 48 h after OLT in patients with CPM was significantly greater than that in patients with cerebral hemorrhage/infarct but without neurologic complications (19.5 +/- 6.54 mmol/L, 10.1 +/- 6.43 mmol/L, 4.5 +/- 4.34 mmol/L, respectively, P<0.05). Plasma osmolality was greatly increased postoperation in patients with CPM. Hypomagnesemia was noted in all patients perioperation, but there were no significant differences between groups. The duration of operation on patients with CPM was longer than that on others (492 +/- 190.05 min, P<0.05). Cyclosporin A (CsA) levels were normal in all patients, but there were significant differences between patients with or without neurologic complications (P<0.05).
CONCLUSION: CPM may be more prevalent following liver transplantation. Although the diagnosis of CPM after OLT can be made by overall neurologic evaluations including magnetic resonance imaging (MRI) of the head, the mortality is still very high. The occurance of CPM may be associated with such factors as hyponatremia, rapid rise of serum sodium concentration, plasma osmolality increase postoperation, the duration of operation, and high CsA levels. Copyright 2004 The WJG Press ISSN

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15300900      PMCID: PMC4572157          DOI: 10.3748/wjg.v10.i17.2540

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  36 in total

1.  Venovenous bypass ahead of mobilization of the liver in orthotopic liver transplantation.

Authors:  Lu-Nan Yan; Wei Wang; Bo Li; Shi-Chun Lu; Tian-Fu Wen; Yong Zeng; Nan-Sheng Cheng; Ji-Chun Zhao; Qi-Yuan Lin; Xiao-Li Chen; Xiao-Ding Wu; Qian-Bin Jia; Yong Zhou; Bin Tu; Yan-Tao Wu
Journal:  Hepatobiliary Pancreat Dis Int       Date:  2003-02

Review 2.  Central pontine myelinolysis.

Authors:  Christian Lampl; Kambiz Yazdi
Journal:  Eur Neurol       Date:  2002       Impact factor: 1.710

3.  Pontine and extrapontine myelinolysis following liver transplantation. Relationship to serum sodium.

Authors:  Z K Wszolek; R D McComb; R F Pfeiffer; R E Steg; R P Wood; B W Shaw; R S Markin
Journal:  Transplantation       Date:  1989-12       Impact factor: 4.939

4.  Central nervous system complications in liver transplant recipients--incidence, timing, and long-term follow-up.

Authors:  D J Bronster; S Emre; P Boccagni; P A Sheiner; M E Schwartz; C M Miller
Journal:  Clin Transplant       Date:  2000-02       Impact factor: 2.863

Review 5.  Subclinical central pontine myelinolysis following liver transplantation.

Authors:  Takeo Kato; Haruo Hattori; Masako Nagato; Tetsuya Kiuchi; Shinji Uemoto; Tatsutoshi Nakahata; Koichi Tanaka
Journal:  Brain Dev       Date:  2002-04       Impact factor: 1.961

6.  Role of organic osmolytes in myelinolysis. A topographic study in rats after rapid correction of hyponatremia.

Authors:  Y H Lien
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

7.  Prevention of myelinolysis in rats by dexamethasone or colchicine.

Authors:  M S Oh; K C Choi; J Uribarri; J Sher; C Rao; H J Carroll
Journal:  Am J Nephrol       Date:  1990       Impact factor: 3.754

8.  Central nervous system lesions in liver transplant recipients: prospective assessment of indications for biopsy and implications for management.

Authors:  C A Bonham; E A Dominguez; M B Fukui; D L Paterson; G A Pankey; M M Wagener; J J Fung; N Singh
Journal:  Transplantation       Date:  1998-12-27       Impact factor: 4.939

Review 9.  Central nervous system lesions in adult liver transplant recipients: clinical review with implications for management.

Authors:  N Singh; V L Yu; T Gayowski
Journal:  Medicine (Baltimore)       Date:  1994-03       Impact factor: 1.889

10.  Liver transplantation in hyponatremic patients with emphasis on central pontine myelinolysis.

Authors:  O Abbasoglu; R M Goldstein; M S Vodapally; L W Jennings; M F Levy; B S Husberg; G B Klintmalm
Journal:  Clin Transplant       Date:  1998-06       Impact factor: 2.863

View more
  11 in total

1.  Central pontine and extrapontine myelinolysis: from epileptic and other manifestations to cognitive prognosis.

Authors:  Céline Odier; Dang Khoa Nguyen; Michel Panisset
Journal:  J Neurol       Date:  2010-02-11       Impact factor: 4.849

Review 2.  Neurocognitive-neurological complications of liver transplantation: a review.

Authors:  Francesca Campagna; A Biancardi; U Cillo; A Gatta; P Amodio
Journal:  Metab Brain Dis       Date:  2010-03-05       Impact factor: 3.584

3.  Tacrolimus-induced Central Pontine Myelinolysis in a Pediatric Liver Transplant Recipient.

Authors:  Kinisha Patel; Jagadeesh Menon; Naresh Shanmugam; Srinivasan Kalyanasundaram; Mohamed Rela
Journal:  J Clin Exp Hepatol       Date:  2021-07-28

4.  Identifying risk factors for central pontine and extrapontine myelinolysis after liver transplantation: a case-control study.

Authors:  Isabelle Morard; Yvan Gasche; Mark Kneteman; Christian Toso; Ariane Mentha; Glenda Meeberg; Gilles Mentha; Norman Kneteman; Emiliano Giostra
Journal:  Neurocrit Care       Date:  2014-04       Impact factor: 3.210

5.  Therapy of central pontine myelinolysis following living donor liver transplantation: Report of three cases.

Authors:  Zhong-Wei Zhang; Yan Kang; Li-Jing Deng; Chuan-Xing Luo; Yan Zhou; Xin-Sheng Xue; Dong Wang; Wan-Hong Yin
Journal:  World J Gastroenterol       Date:  2009-08-21       Impact factor: 5.742

6.  Corticospinal tract and pontocerebellar fiber of central pontine myelinolysis.

Authors:  Yong Min; Sung-Hee Park; Seung-Bae Hwang
Journal:  Ann Rehabil Med       Date:  2012-12-28

7.  The Effect of Intraoperative Restricted Normal Saline during Orthotopic Liver Transplantation on Amount of Administered Sodium Bicarbonate.

Authors:  Mohammad Ali Sahmeddini; Farahzad Janatmakan; Mohammad Bagher Khosravi; Sina Ghaffaripour; Mohammad Hossein Eghbal; Sakine Shokrizadeh
Journal:  Iran J Med Sci       Date:  2014-05

Review 8.  Cerebral Diseases in Liver Transplant Recipients: Systematic Review of Clinical Evidence.

Authors:  Paula Dudek; Paweł Andruszkiewicz; Remigiusz Gelo; Rafael Badenes; Federico Bilotta
Journal:  J Clin Med       Date:  2022-02-13       Impact factor: 4.241

9.  Hyponatremia in the intensive care unit: How to avoid a Zugzwang situation?

Authors:  Cédric Rafat; Martin Flamant; Stéphane Gaudry; Emmanuelle Vidal-Petiot; Jean-Damien Ricard; Didier Dreyfuss
Journal:  Ann Intensive Care       Date:  2015-11-09       Impact factor: 6.925

10.  A Case of Central Pontine Myelinolysis Caused by Hypophosphatemia Secondary to Refeeding Syndrome.

Authors:  Chikara Yamashita; Hiroshi Shigeto; Norihisa Maeda; Takako Torii; Yasumasa Ohyagi; Jun-Ichi Kira
Journal:  Case Rep Neurol       Date:  2015-10-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.